671
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Three-month paliperidone palmitate - a new treatment option for schizophrenia

&
Pages 899-904 | Received 18 Mar 2016, Accepted 17 May 2016, Published online: 06 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Giovanna Cirnigliaro, Vera Battini, Rita Cafaro, Giulia Mosini, Simone Vanzetto, Tiziano Prodi, Monica Macellaro, Rodolfo Leuzzi, Dario Conti, Carla Carnovale & Bernardo Dell’Osso. (2023) Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting. Expert Review of Neurotherapeutics 23:11, pages 1031-1039.
Read now
Miquel Bioque & Miquel Bernardo. (2018) The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia. Expert Opinion on Pharmacotherapy 19:14, pages 1623-1629.
Read now
Claudio Brasso, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni & Paola Rocca. (2017) Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia. Neuropsychiatric Disease and Treatment 13, pages 2767-2779.
Read now
Thomas R. Einarson, Basil G. Bereza, Fadi Tedouri, Kristel Van Impe, Tom R. Denee & Pieter J. T. Dries. (2017) Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands. Journal of Medical Economics 20:11, pages 1187-1199.
Read now

Articles from other publishers (4)

Yujie Shi, An Lu, Xiangyu Wang, Zakia Belhadj, Jiancheng Wang & Qiang Zhang. (2021) A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharmaceutica Sinica B 11:8, pages 2396-2415.
Crossref
Salvatore Gentile. (2019) Discontinuation rates during long‐term, second‐generation antipsychotic long‐acting injection treatment: A systematic review. Psychiatry and Clinical Neurosciences 73:5, pages 216-230.
Crossref
Salvatore Gentile. (2018) Safety concerns associated with second-generation antipsychotic long-acting injection treatment. A systematic update. Hormone Molecular Biology and Clinical Investigation 36:2.
Crossref
Adriana ForteaDaniel IlzarbeLaura EspinosaMireia SolerdelcollClara de CastroGiovanni OrioloGisela SugranyesInmaculada Baeza. (2018) Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study. Journal of Child and Adolescent Psychopharmacology 28:4, pages 252-257.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.